The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis
ClinicalTrials.gov ID
NCT02260310
Lead Sponsor
Chengdu PLA General HospitalOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Not Applicable
Enrollment
100Estimated
Last Update Posted
Apr 4, 2017Actual
Start Date
Oct 2014
Primary Completion Date
Jan 2018Estimated
Completion Date
Jan 2018Estimated
Brief Summary
The purpose of this study is to evaluate the effect of acupuncture protocol involving in Weizhong (BL4) and Huantiao (GB30) points in treating ankylosing spondylitis.
Ankylosing Spondylitis
Weizhong and Huantiao
A-shi point
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Eligible adult (≥18 years of age) patients
had a diagnosis of AS for at least 3 months defined as definite by the 1984 modified New York criteria
Eligible patients also had a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of ≥4 (0-10 cm scale)
A visual analogue scale (VAS) score for total back pain of ≥4 (0-10 cm scale)
Exclusion Criteria:
Had received prior Acupuncture therapy
With complete ankylosis of the spine, defined as the presence of bridging syndesmophytes at all intervertebral levels of the cervical and lumbar spine on lateral view spinal radiographs
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Single
No central contacts
There are no central contacts for this study.
270 Rongdu street, Jin-niu district,Rheumatology Center of Integrated Medicine, General Hospital of Chengdu Military Area Command PLA，